Skip to main content
Clinical Trials/JPRN-UMIN000050429
JPRN-UMIN000050429
Recruiting
N/A

A prospective cohort study of treatment efficacy of biologics for severe asthma in children and young adults for prevention of airway remodeling - A prospective cohort study of treatment efficacy of biologics for severe asthma in children and young adults for prevention of airway remodeling

ational Mie Hospital0 sites50 target enrollmentMarch 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bronchial asthma
Sponsor
ational Mie Hospital
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 1, 2023
End Date
March 31, 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Mie Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Those who have already started and are stable on the use of the following biologics.(omalizumab, mepolizumab, venlalizumab, dupilumab, tezepelumab) 2\) Those who have requested to opt out of this study.

Outcomes

Primary Outcomes

Not specified

Similar Trials